NCT02726438View on ClinicalTrials.gov

Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Bone Diseases, Infectious
Interventions
DRUG

Debio 1450

Debio 1450, 40 mg, powder for oral solution, for reconstitution in 5% dextrose in water.

Trial Locations (2)

59701

Mercury St Medical Group, PLLC, Butte

91941

eStudySite, La Mesa

Sponsors
All Listed Sponsors
lead

Debiopharm International SA

INDUSTRY